Yoshihiko Hidaka

698 total citations
32 papers, 398 citations indexed

About

Yoshihiko Hidaka is a scholar working on Immunology, Nephrology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yoshihiko Hidaka has authored 32 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 11 papers in Nephrology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yoshihiko Hidaka's work include Complement system in diseases (13 papers), Renal Diseases and Glomerulopathies (11 papers) and Influenza Virus Research Studies (4 papers). Yoshihiko Hidaka is often cited by papers focused on Complement system in diseases (13 papers), Renal Diseases and Glomerulopathies (11 papers) and Influenza Virus Research Studies (4 papers). Yoshihiko Hidaka collaborates with scholars based in Japan, Australia and United States. Yoshihiko Hidaka's co-authors include Shoji Kagami, Yoshihiro Fujimura, Masaomi Nangaku, Hirokazu Okada, Shinya Kaname, Hiroshi Hataya, Norimitsu Inoue, Shuichi Ito, Takayuki Honda and Shigeyuki Kawa and has published in prestigious journals such as Frontiers in Immunology, Biochimica et Biophysica Acta (BBA) - General Subjects and Journal of the Neurological Sciences.

In The Last Decade

Yoshihiko Hidaka

32 papers receiving 390 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yoshihiko Hidaka Japan 13 235 166 88 53 53 32 398
Maud François France 9 174 0.7× 169 1.0× 93 1.1× 18 0.3× 29 0.5× 17 317
Jakub Zieg Czechia 11 80 0.3× 109 0.7× 29 0.3× 19 0.4× 7 0.1× 46 309
Bengt von Zur‐Mühlen Sweden 11 61 0.3× 33 0.2× 15 0.2× 25 0.5× 9 0.2× 18 288
F. J. Bemelman Netherlands 10 130 0.6× 31 0.2× 19 0.2× 120 2.3× 4 0.1× 22 327
Antoine Dürrbach France 11 48 0.2× 70 0.4× 12 0.1× 30 0.6× 5 0.1× 16 336
Marjan Afrouzian United States 10 133 0.6× 35 0.2× 9 0.1× 44 0.8× 6 0.1× 21 396
M C Vial France 13 297 1.3× 34 0.2× 31 0.4× 27 0.5× 2 0.0× 24 515
Luigi Porcaro Italy 12 85 0.4× 28 0.2× 19 0.2× 64 1.2× 4 0.1× 22 450
P. Gollapudi United States 7 125 0.5× 112 0.7× 20 0.2× 61 1.2× 9 369
C. Ross United Kingdom 9 61 0.3× 86 0.5× 17 0.2× 39 0.7× 2 0.0× 16 281

Countries citing papers authored by Yoshihiko Hidaka

Since Specialization
Citations

This map shows the geographic impact of Yoshihiko Hidaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshihiko Hidaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshihiko Hidaka more than expected).

Fields of papers citing papers by Yoshihiko Hidaka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshihiko Hidaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshihiko Hidaka. The network helps show where Yoshihiko Hidaka may publish in the future.

Co-authorship network of co-authors of Yoshihiko Hidaka

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshihiko Hidaka. A scholar is included among the top collaborators of Yoshihiko Hidaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshihiko Hidaka. Yoshihiko Hidaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tsujimoto, Hiroshi, Tadafumi Yokoyama, Naotoshi Sugimoto, et al.. (2024). Case report: A family of atypical hemolytic uremic syndrome involving a CFH::CFHR1 fusion gene and CFHR3-1-4-2 gene duplication. Frontiers in Immunology. 15. 1 indexed citations
2.
Okamura, Hiroshi, Hirohisa Nakamae, Takero Shindo, et al.. (2021). Early Elevation of Complement Factor Ba Is a Predictive Biomarker for Transplant-Associated Thrombotic Microangiopathy. Frontiers in Immunology. 12. 695037–695037. 22 indexed citations
3.
4.
Fujita, Yoko, Masahiko Yazawa, Tomonori Imamura, et al.. (2019). Eculizumab for Severe Thrombotic Microangiopathy Secondary to Surgical Invasive Stress and Bleeding. Internal Medicine. 59(1). 93–99. 3 indexed citations
5.
Wakamiya, Nobutaka, Katsuki Ohtani, Yoshihiko Hidaka, & Norimitsu Inoue. (2019). [New Complement Therapeutics in Complement-Related Diseases].. PubMed. 71(6). 555–564. 3 indexed citations
6.
Hidaka, Yoshihiko, et al.. (2018). Childhood asymptomatic renal arteriovenous fistula 5 years after renal biopsy. Pediatrics International. 60(6). 601–602. 1 indexed citations
7.
Kato, Hideki, Yoshitaka Miyakawa, Yoshihiko Hidaka, et al.. (2018). Safety and effectiveness of eculizumab for adult patients with atypical hemolytic–uremic syndrome in Japan: interim analysis of post-marketing surveillance. Clinical and Experimental Nephrology. 23(1). 65–75. 16 indexed citations
8.
Uchida, Mitsuo, Minoru Kaneko, Yoshihiko Hidaka, et al.. (2018). High vaccination coverage is associated with low epidemic level of seasonal influenza in elementary schools: an observational study in Matsumoto City, Japan. BMC Infectious Diseases. 18(1). 128–128. 11 indexed citations
9.
Ito, Shuichi, Yoshihiko Hidaka, Norimitsu Inoue, et al.. (2018). Safety and effectiveness of eculizumab for pediatric patients with atypical hemolytic–uremic syndrome in Japan: interim analysis of post-marketing surveillance. Clinical and Experimental Nephrology. 23(1). 112–121. 28 indexed citations
10.
Roy, Nitai, Katsuki Ohtani, Yoshihiko Hidaka, et al.. (2016). Three pentraxins C-reactive protein, serum amyloid p component and pentraxin 3 mediate complement activation using Collectin CL-P1. Biochimica et Biophysica Acta (BBA) - General Subjects. 1861(2). 1–14. 20 indexed citations
11.
Ito, Naoko, Hiroshi Hataya, Ken Saida, et al.. (2015). Efficacy and safety of eculizumab in childhood atypical hemolytic uremic syndrome in Japan. Clinical and Experimental Nephrology. 20(2). 265–272. 20 indexed citations
12.
13.
Hidaka, Yoshihiko, Yuji Inaba, Kazuyuki Matsuda, et al.. (2014). Cytokine production profiles in chronic relapsing–remitting experimental autoimmune encephalomyelitis: IFN-γ and TNF-α are important participants in the first attack but not in the relapse. Journal of the Neurological Sciences. 340(1-2). 117–122. 29 indexed citations
14.
Saida, Ken, Yuji Kamijo, Yoshihiko Hidaka, et al.. (2013). A case of adult Dent disease in Japan with advanced chronic kidney disease. CEN Case Reports. 3(2). 132–138. 1 indexed citations
15.
Kagami, Shoji, Hirokazu Okada, Shinya Kaname, et al.. (2012). [Diagnostic criteria of atypical hemolytic uremic syndrome].. PubMed. 2(2). 91–3. 3 indexed citations
16.
Hirabayashi, Koichi, Masaaki Shiohara, Takefumi Suzuki, et al.. (2012). Critical Illness Polyneuropathy and Myopathy Caused by Bacillus Cereus Sepsis in Acute Lymphoblastic Leukemia. Journal of Pediatric Hematology/Oncology. 34(3). e110–e113. 4 indexed citations
17.
Hidaka, Yoshihiko, et al.. (2011). Factor H gene variants in Japanese: Its relation to atypical hemolytic uremic syndrome. Molecular Immunology. 49(1-2). 48–55. 5 indexed citations
18.
Suga, Kenichi, Shuji Kondo, Yukiko Kinoshita, et al.. (2010). A case of dense deposit disease associated with a group A streptococcal infection without the involvement of C3NeF or complement factor H deficiency. Pediatric Nephrology. 25(8). 1547–1550. 20 indexed citations
19.
Hirabayashi, Koichi, Masaaki Shiohara, Shoji Saito, et al.. (2010). Polymyxin‐direct hemoperfusion for sepsis‐induced multiple organ failure. Pediatric Blood & Cancer. 55(1). 202–205. 3 indexed citations
20.
Mutoh, Kozo, et al.. (2001). Possible induction of systemic lupus erythematosus by zonisamide. Pediatric Neurology. 25(4). 340–343. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maud François Breakdown of academic impact, for papers by Jakub Zieg Breakdown of academic impact, for papers by Bengt von Zur‐Mühlen Breakdown of academic impact, for papers by F. J. Bemelman Breakdown of academic impact, for papers by Antoine Dürrbach Breakdown of academic impact, for papers by Marjan Afrouzian Breakdown of academic impact, for papers by M C Vial Breakdown of academic impact, for papers by Luigi Porcaro Breakdown of academic impact, for papers by P. Gollapudi Breakdown of academic impact, for papers by C. Ross
Rankless by CCL
2026